Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...
Provision of robust, sustained, and predictable research funding for the National Institutes of Health (NIH) fuels cancer prevention, detection,...
As social media continues to rapidly grow as a leading source of news and information, it has evolved to...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
As the American population grows ever more diverse, cancer researchers are discovering that digging deep into demographic information can...
Last month, federal agencies approved changes to the Common Rule, which regulates the way federally funded biomedical research is...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
Chemical probes are small, drug-like molecules that are useful in interrogating biology in disease models. In order for a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...